The MakeSense Advisory Board
.jpeg)
Prof. Amir Tirosh
MD, PhD
Director of the Center for Diabetes Research and Endocrinology at Sheba Hospital
Senior Endocrinology Specialist
Asst. Professor Harvard Medical School and Brigham and Women's Hospital
Eyal Dassau
PhD
Director, Biomedical Systems Engineering Research Group at Harvard John A. Paulson School of Engineering and Applied Sciences
Adjunct Faculty, Joslin Diabetes Center, Boston, MA and Adjunct Senior Investigator at Sansum Diabetes Research Institute (SDRI)
Investors
Boutique early-stage fund, focused on market disruptive ventures, based on cutting-edge Machine Learning and Artificial Intelligence technologies. Along with an in-house algorithm team and experienced partners, Random Forest provides a unique offering of support to those startups it chooses to invest in.
Rafi Gidron
Rafi has extensive experience as founder, manager, and angel investor in multiple disciplines including Internet, mobile, telecommunications, nanotechnology, neurotechnology, and medical devices.
Dr. Gidron was the founder and chairman of Israel Brain Technologies, an initiative under the auspices of late president Shimon Peres, that accelerates industry to solve for brain diseases and brain-related technologies.
In 1998 he co-founded Chromatis Networks, that was sold to Lucent in May 2000 for $4.75 billion.
Welltech1 invests in and accelerates wellness startups with the ultimate goal of increasing viability, seeking additional investment and connecting to global partners immersed in the wellness market. Welltech1’s growth program provides startups with know-how, a dedicated professional team of wellness experts, business advisors, global partners, and a gateway to a $4.5 trillion wellness market worldwide.